Christian Werner, MD

Title: Executive Director, Global Medical Affairs, and Global Duchenne Muscular Dystrophy Lead PTC Therapeutics

Bio: Dr. Werner is Executive Director, Global Medical Affairs, and Global Duchenne Muscular Dystrophy Lead at PTC Therapeutics, Frankfurt, and has held this position since 2021. Prior to this role, Dr. Werner was Senior Director, Medical Affairs, D-A-CH, and Executive Director, Medical Affairs – Europe and Northern Europe at PTC Therapeutics, Frankfurt holding positions from 2016. Dr. Werner was previously Senior Medical Director, Otsuka Pharma GmbH, Frankfurt from 2005 to 2016, and worked in the Psychiatry and Psychotherapy and Neurology departments at the Heinrich-Heine University, Duesseldorf, Germany from 1998 to 2005. Dr. Werner is a specialist in psychiatry and psychotherapy, health economist (ebs) and earned his medical degree from Heinrich-Heine University, Duesseldorf, Germany.

2023 FUTURES: RNA targeted Therapeutics Sessions Part 1

A brief primer on the RNA-targetd therapeutic approach to treating Duchenne, and updates from relevant companies in the space. These presentations will be followed by a moderated Q&A opportunity.

Ash Dugar, PhD

Senior Vice President, Medical Affairs

Dyne Therapeutics

Adam Gold, PhD

Medical Science Liasion

NS Pharma

Kevin Flanigan, MD

Director, Center for Gene Therapy Nationwide Children's Hospital

Karin Lucas, Ph.D

West Medical Science Liaison Team Lead, Global Medical Affairs Sarepta Therapeutics

Christian Werner, MD

Executive Director, Global Medical Affairs, and Global Duchenne Muscular Dystrophy Lead PTC Therapeutics